INVO Bioscience, Inc. (INVO) - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on November 16, 2021, reporting events as of November 15, 2021. The filing serves to announce the Company's financial results for the period ended September 30, 2021. The registrant, INVO Bioscience, Inc., is incorporated in Nevada and trades on The Nasdaq Stock Market LLC under the symbol "INVO."
Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing references a press release (Exhibit 99.1) containing these details but does not reproduce the financial data within the body of this 8-K document.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It solely indicates that results for the period ended September 30, 2021, have been issued.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, specific risk factors, or unusual items. It includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial results for the period ended September 30, 2021, by reviewing Exhibit 99.1 (Press Release) attached to this filing, as the 8-K text itself lacks numerical data.
- Confirm the Company's current cash position and burn rate, as these are critical for a biotechnology firm but are not listed in this summary document.
- Note that the information regarding financial results is furnished and not "filed" for liability purposes under Section 18 of the Exchange Act.